Yahoo Finance

Wegovy® (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious ...

Wegovy ® (semaglutide injection) granted conditional marketing authorization for the treatment of non-cirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to ...
EurekAlert!

Semaglutide can have lifetime cost and health benefits for non-diabetic overweight or obese individuals with heart disease

A detailed analysis in the Canadian Journal of Cardiology of the cost-effectiveness of semaglutide shows that with price reductions, it could meet the benchmark for healthcare value, urging ...
ktiv

Healthbeat 4: CNOS introduces Semaglutide injections to patients for weight loss

SIOUX CITY (KTIV) - CNOS is offering another weight loss alternative. CNOS Started prescribing the medication, Semaglutide also known as GLP1 in January this year. It’s a non-surgical weight loss ...
Morningstar

BioNxt Launches Feasibility Study for Semaglutide Oral Thin Film as Alternative to Injection/Tablets

VANCOUVER, BC / ACCESS Newswire / June 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC:BNXTF)(FSE:BXT), is pleased to announce the launch of a feasibility study for the ...

This Weight Loss Strategy Is 5 Times More Effective Than Ozempic, According to Scientists

After two years, people who undergo metabolic and bariatric surgery achieve weight loss that is about five times greater than ...
MarketWatch

Wegovy(R) (semaglutide injection) Receives Conditional Marketing Authorization from Health Canada as the First and Only Treatment for Adults with Non-Cirrhotic MASH, a Serious ...

The MarketWatch News Department was not involved in the creation of this content. -- Wegovy(R) (semaglutide injection) granted conditional marketing authorization for the treatment of non-cirrhotic ...